Decreased Somatostatin (SRIF) Secretion is a pharmacological drug class in the Physiologic Effect taxonomy.

Physiologic Effect · N0000008923

Decreased Somatostatin (SRIF) Secretion

Pharmacological class containing 0 drugs per the Physiologic Effect taxonomy.

Need clinical context — common uses, side effects, or interactions for this class?

Ask GoDavaii AI about Decreased Somatostatin (SRIF) Secretion

Common questions about Decreased Somatostatin (SRIF) Secretion

What is the Decreased Somatostatin (SRIF) Secretion drug class?
Decreased Somatostatin (SRIF) Secretion is a pharmacological class in the Physiologic Effect taxonomy, classification code N0000008923. It groups together drugs that share a similar mechanism of action, chemical structure or therapeutic use.
Which drugs are part of the Decreased Somatostatin (SRIF) Secretion class?
The complete member list for Decreased Somatostatin (SRIF) Secretion is curated from the NIH RxClass public-domain dataset. Use the GoDavaii AI search to ask about specific drugs in this class for India-specific context.
What does Physiologic Effect mean?
Physiologic Effect is one of the standard taxonomies used by the NIH National Library of Medicine to organise drugs. Different taxonomies group drugs by different criteria - some by chemical structure, some by what they do in the body, some by therapeutic intent. Together these classifications make medical research, prescribing and education more consistent across the world.
Where can I get plain-language clinical context for the Decreased Somatostatin (SRIF) Secretion class?
For plain-language clinical context - common uses, side effects, drug interactions and what the class means for an Indian patient - ask GoDavaii's Health AI. It works in 90+ languages, is free and needs no signup. Tap "Ask GoDavaii AI about Decreased Somatostatin (SRIF) Secretion" above.

Source: NIH RxClass — National Library of Medicine, public domain. Class taxonomy: Physiologic Effect. View on RxClass ↗